Europe drives Swedencare growth in first quarter

Europe became the main growth engine for Swedencare in the first quarter of 2026, helping offset softer reported growth at the group level. Swedencare reported Q1 net revenue of SEK 650.3 million, up 1% year over year, while organic, currency-adjusted growth reached 11%. The company said momentum was strongest in Europe, where revenue rose 38% to SEK 153.8 million and organic growth reached 21%, lifting the region to 24% of group sales from 17% a year earlier. Swedencare tied that performance to faster online sales, especially dental products on Amazon UK, a limited European launch of NaturVet on Amazon and Zooplus, and the contribution from Summit Veterinary Pharmaceuticals, which added SEK 26.0 million in the quarter. Group growth was also driven by dental and pharma products, with pharma revenue in the production segment nearly doubling from the prior-year period. (swedencare.com)

Why it matters: For veterinary professionals, the quarter shows how pet health suppliers are leaning harder into Europe, online channels, and adjacent therapeutic categories to drive growth. Summit is especially relevant because it expands Swedencare’s reach in veterinary-focused animal health specials, a market the company entered through its March 2025 acquisition announcement and April 2025 closing. At the same time, Swedencare is using Europe to scale products that already have traction in oral care, supplements, dermatology, and contract manufacturing, which could shape future channel strategy, product availability, and competitive pressure across clinics, retail, and e-commerce. (swedencare.com)

What to watch: Swedencare said it’s preparing a full-scale European launch of NaturVet later in 2026 and plans a broader rollout of ProDen PlaqueOff Crème for cats in Europe as availability improves. (storage.mfn.se)